CVE-2023-33861

IBM Security ReaQta improper certificate validation

Description

IBM Security ReaQta EDR 3.12 could allow an attacker to spoof a trusted entity by interfering with the communication path between the host and client.

Remediation

Solution:

  • IBM encourages customers to update their systems promptly.  IBM Security QRadar EDR 3.12.17

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.03%
Vendor Advisory ibm.com
Affected: IBM Security ReaQta EDR
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/7233972 vendor advisory patch

Frequently Asked Questions

What is the severity of CVE-2023-33861?
CVE-2023-33861 has been scored as a medium severity vulnerability.
How to fix CVE-2023-33861?
To fix CVE-2023-33861: IBM encourages customers to update their systems promptly.  IBM Security QRadar EDR 3.12.17
Is CVE-2023-33861 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-33861 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-33861?
CVE-2023-33861 affects IBM Security ReaQta EDR.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.